Truckers With Robot Hearts Seek Permission to Cross State Lines
Published Date: 1/15/2025
Notice
Summary
The FMCSA got requests from two people with special heart devices called ICDs who want to drive big commercial trucks across state lines. Normally, folks with certain heart problems can’t drive these trucks, but if these exemptions are approved, these drivers could hit the road again. You’ve got until February 14, 2025, to share your thoughts—no money changes yet, just a chance to speak up!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Two Drivers Seek Exemptions to Drive
FMCSA received exemption applications from two drivers with ICDs that, if granted, would let those individuals operate commercial motor vehicles in interstate commerce. The applicants are Micos Mims (Alabama, ICD implanted March 6, 2023) and Paul Siefker (Ohio, ICD/pacemaker implanted July 6, 2020); FMCSA may grant exemptions up to 5 years, and typically grants medical exemptions for 2 years to align with medical certification. The public may comment on these petitions by February 14, 2025.
ICDs Currently Disqualify CMV Drivers
If you have an implantable cardioverter defibrillator (ICD), federal medical advisory criteria treat ICDs as disqualifying because of the risk of syncope. The physical qualification standard in Sec. 391.41(b)(4) bars people with certain cardiovascular diagnoses from operating commercial motor vehicles (CMVs) in interstate commerce.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-18533, The RBB Fund Trust and Millburn Ridgefield LLC
2026-18536, Self-Regulatory Organizations; Texas Stock Exchange LLC; Order Instituting Proceedings To Determine Whether To Approve or Disapprove a Proposed Rule Change To Amend Exchange Rule 13.003 Related to Proxy Voting
2026-18530, Fortress Investment Group LLC, et al.-Intra-Corporate Family Transaction Exemption
2026-18605, Emran Mohammad, RN, APRN, CNP; Decision and Order
2026-18597, Craig Cohen, DPM; Decision and Order
2026-18599, Cheryl White, N.P.; Decision and Order
Previous / Next Documents
Previous: 2025-00748, Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders
The FMCSA is giving 13 drivers with epilepsy or seizure disorders a green light to drive commercial trucks across state lines, as long as they take their medication and stay safe. These special permissions started on December 31, 2024, and last until the end of 2026. This change helps skilled drivers keep working without risking safety or breaking rules.
Next: 2025-00750, Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ALHEMO (concizumab-mtci)
The FDA just gave a special fast-track ticket called a Priority Review Voucher to Novo Nordisk for their new rare pediatric disease drug, ALHEMO, approved in December 2024. This voucher helps speed up the review of future medicines, benefiting patients with rare diseases and encouraging companies to develop more treatments. This move affects drug makers and could speed up new medicine approvals, saving time and possibly money.